DEA temporarily extends Schedule I status of synthetic cannabinoid

The U.S. Drug Enforcement Administration temporarily extended the Schedule I status of the synthetic cannabinoid MAB-CHMINACA for one year past its current expiration of Feb. 4, or until a permanent scheduling action for the substance is complete.